| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-09 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-09 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-08 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-08 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-07 |